Disc Medicine, Inc. (IRON) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 287 transactions totaling $345.9M, demonstrating a bearish sentiment with -$287.9M in net insider flow. The most recent transaction on Feb 10, 2026 involved a transaction of 82,800 shares valued at $0.
No significant insider buying has been recorded for IRON in the recent period.
No significant insider selling has been recorded for IRON in the recent period.
Based on recent SEC filings, insider sentiment for IRON is bearish with an Insider Alignment Score of 8/100 and a net flow of -$287.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Disc Medicine, Inc. (IRON) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading IRON stock, having executed 287 transactions in the past 90 days. The most active insider is Kevin Bitterman (Executive), who has made 72 transactions totaling $63.3M.
Get notified when executives and directors at IRON file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | D. Quisel John | Executive | Award | 82,800 | $N/A | $0 | |
| Feb 10, 2026 | D. Quisel John | Executive | Award | 55,200 | $N/A | $0 | |
| Feb 10, 2026 | M. Franchi Jean | Chief Financial Officer | Award | 25,500 | $N/A | $0 | C-Suite |
| Feb 10, 2026 | M. Franchi Jean | Chief Financial Officer | Award | 19,000 | $N/A | $0 | C-Suite |
| Feb 10, 2026 | Yen-wen Yu Jonathan | Chief Operating Officer | Award | 25,500 | $N/A | $0 | C-Suite |
| Feb 10, 2026 | Yen-wen Yu Jonathan | Chief Operating Officer | Award | 17,000 | $N/A | $0 | C-Suite |
| Feb 10, 2026 | Jacob Savage William | Chief Medical Officer | Award | 25,500 | $N/A | $0 | |
| Feb 10, 2026 | Jacob Savage William | Chief Medical Officer | Award | 17,000 | $N/A | $0 | |
| Feb 10, 2026 | Stephenson Pamela | Chief Commercial Officer | Award | 25,500 | $N/A | $0 | |
| Feb 10, 2026 | Stephenson Pamela | Chief Commercial Officer | Award | 17,000 | $N/A | $0 | |
| Feb 10, 2026 | Khara Rahul | Chief Legal Officer | Award | 25,500 | $N/A | $0 | |
| Feb 10, 2026 | Khara Rahul | Chief Legal Officer | Award | 17,000 | $N/A | $0 | |
| Jan 20, 2026 | Khara Rahul | Chief Legal Officer | Option Exercise | 1,000 | $N/A | $0 | |
| Jan 20, 2026 | Khara Rahul | Chief Legal Officer | Sale | 1,000 | $69.74 | $69.7K | |
| Jan 20, 2026 | Khara Rahul | Chief Legal Officer | Option Exercise | 1,000 | $13.50 | $13.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 204 | $316.9M | 87.3% |
Purchase(P) | 14 | $29.0M | 8.0% |
Award(A) | 20 | $15.0M | 4.1% |
Exercise(M) | 43 | $2.1M | 0.6% |
Other(J) | 6 | $0 | 0.0% |
Insider selling pressure at Disc Medicine, Inc. has increased, with 23 insiders executing 287 transactions across all time. Total sales of $316.9M significantly outpace purchases of $29.0M, resulting in a net outflow of $287.9M. This selling activity appears largely discretionary, which may warrant closer attention from investors.